{"id":"W2146956830","doi":"10.1136/gut.2005.083113","title":"Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy","year":2006,"lang":"en","type":"article","venue":"Gut","topic":"Hepatitis C virus research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Roche (Canada); University of Manitoba; Canadian Society of Intestinal Research; Queen Elizabeth II Health Sciences Centre; University of Alberta; BC Centre for Disease Control; University Health Network; Toronto General Hospital; Royal Victoria Hospital; Vancouver Hospital and Health Sciences Centre","funders":"Jewish General Hospital; London Health Sciences Centre; Hamilton Health Sciences","keywords":"Ribavirin; Medicine; Internal medicine; Peginterferon alfa-2a; Gastroenterology; Population; Cohort; Hepatitis C; Interferon; Hepatitis C virus; Genotype; Chronic hepatitis; Clinical endpoint; Immunology; Randomized controlled trial; Virus","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001760797,0.0004215092,0.001083712,0.0003567504,0.0004798561,0.0003966898,0.0002596214,0.0007151285,0.0007914795],"category_scores_gemma":[0.002066662,0.0003063675,0.000542671,0.0004436253,0.0003163003,0.0003946667,0.0002542197,0.0004929458,0.0001728912],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004933169,"about_ca_system_score_gemma":0.0005323128,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008108307,"about_ca_topic_score_gemma":0.001319339,"domain_scores_codex":[0.9993081,0.0003791128,0.00007562793,0.00007464212,0.0000822802,0.00008020603],"domain_scores_gemma":[0.9989983,0.0003036679,0.0003201511,0.00004733121,0.00005008913,0.0002804163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1050902,0.005191385,0.8049126,0.0005314784,0.0006946019,0.001747299,0.0006492887,0.001310618,0.01063851,0.00006614251,0.0006410239,0.06852673],"study_design_scores_gemma":[0.01929448,0.1328579,0.8380219,0.00012501,0.0005503708,0.003107922,0.0003565589,0.002328661,0.001621105,0.00008953414,0.001607799,0.00003890052],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992775,0.000482372,0.00003313746,0.00003708319,0.00000654194,0.00003777347,0.00002728714,0.000003177669,0.00009520697],"genre_scores_gemma":[0.9993001,0.0002451707,0.0001495607,0.00007156783,0.000029748,0.00005069153,0.00008267172,0.000001111486,0.00006929524],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001760797,"threshold_uncertainty_score":0.009312093,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02087390925188778,"score_gpt":0.3000198028442696,"score_spread":0.2791458935923818,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}